IDRI Announces New EVP Business Development & External Affairs: Erik Iverson to Join IDRI from Bill & Melinda Gates Foundation
SEATTLE, Aug. 3, 2011 /PRNewswire-USNewswire/ -- The Infectious Disease Research Institute (IDRI) announced today that Erik Iverson, Associate General Counsel for Global Health at the Bill & Melinda Gates Foundation, will join IDRI in September as its EVP Business Development & External Affairs. In this newly created position, Iverson will work within the IDRI management team to further the organization's development of proprietary programs in vaccines, diagnostics and treatments for infectious disease.
"We are extremely pleased to have Erik join our team," said Stewart Parker, IDRI CEO. "He brings tremendous experience and relationships, along with a deep commitment to our global health mission." This new position dedicated to securing partnerships, and increasing its visibility to a broader audience, will accelerate IDRI's focus on providing pragmatic solutions to global health problems.
For the last seven years Iverson has served as the Gates Foundation's Associate General Counsel, Global Health. Hired as the Foundation's second attorney, he has worked on a broad range of core activities, including legal and collaborative agreements, intellectual property, and creative financing mechanisms and investments.
"IDRI has been conducting important research since its inception in 1993 and has several exciting products on the market now," said Iverson. "I look forward to helping strengthen IDRI's product development efforts and raising awareness of its impressive work and important successes."
About IDRI – Translating science into global health solutions
IDRI is a Seattle-based not-for-profit organization committed to applying innovative science to the research and development of products to prevent, detect, and treat infectious diseases of poverty. By integrating capabilities — including early stage drug discovery, preclinical testing, manufacturing, and clinical trials — IDRI strives to create an efficient pathway bringing scientific innovation from the laboratory to the people who need it most.
SOURCE Infectious Disease Research Institute (IDRI)
RELATED LINKS
http://www.idri.org
More by this Source
IDRI and Medicago Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine
Apr 17, 2013, 14:51 ET
IDRI and Medicago to present data at the World Vaccine Congress
Apr 09, 2013, 07:00 ET
IDRI And OrangeLife Register Rapid Diagnostic For Leprosy For Use In Brazil
Jan 24, 2013, 08:30 ET
Featured Video
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.




